In case of adrenal cancer, Brain lower grade glioma, colorectal, liver, and testicular cancer, patients showed a range of 5 to 10% amplification and or up-regulation in EIF4G1 (Additional file 1: Figure S2A–E). Here, EIF4G1 is linked to central nervous system cancer.